SCHEMBL25355683

SCHEMBL25355683

O=c1c(Cl)c(NC2CCCOC2)cnn1-c1ccc(C2CCCC2)cc1

nearest known ligand 0.42

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 16/20 0.42
▸ NPBWR1 P48145 1/20 0.41
▸ MCHR1 Q99705 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ BPTF Q12830 2/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25994611 0.89 NPC1 (0.44) KAT2BNPBWR1MCHR1NPC1RAB9A
SCHEMBL25356467 0.83 CA12 (0.42) NPBWR1MCHR1NPC1RAB9ASMN1; SMN2
SCHEMBL25354605 0.83 CA12 (0.42) NPBWR1MCHR1NPC1RAB9ASMN1; SMN2
SCHEMBL25353970 0.83 CA12 (0.42) NPBWR1MCHR1NPC1RAB9ASMN1; SMN2
SCHEMBL25994467 0.82 NPBWR1 (0.39) NPBWR1MCHR1NPC1RAB9ASMN1; SMN2
SCHEMBL25996531 0.82 CA12 (0.41) NPBWR1MCHR1NPC1RAB9ASMN1; SMN2
SCHEMBL25996529 0.82 CA12 (0.41) NPBWR1MCHR1NPC1RAB9ASMN1; SMN2
SCHEMBL25356824 0.82 NPC1 (0.44) KAT2BNPBWR1MCHR1NPC1RAB9A
SCHEMBL25356829 0.82 NPC1 (0.44) KAT2BNPBWR1MCHR1NPC1RAB9A
SCHEMBL25994566 0.82 NPC1 (0.44) KAT2BNPBWR1MCHR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023122778-A1 PYRIDAZINONE DERIVATIVES USEFUL AS T CELL ACTIVATORS GOSSAMER BIO SERVICES, INC. (US) 2023-06-29 — — WO disclosed
WO-2023122778-A1 PYRIDAZINONE DERIVATIVES USEFUL AS T CELL ACTIVATORS GOSSAMER BIO SERVICES, INC. (US) 2023-06-29 — — WO disclosed
Send feedback